Related Experiment Video
Updated: Aug 13, 2026
10:16
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
ICA512 autoantibody radioassay
R Gianani1, D U Rabin, C F Verge
1Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA.
Diabetes
|November 1, 1995
Summary
Researchers developed a sensitive radioassay for autoantibodies to ICA512 (islet cell antigen 512), a key neuroendocrine islet autoantigen. This new assay shows higher sensitivity than existing methods for detecting diabetes-associated autoantibodies.
Area of Science:
- Immunology
- Endocrinology
- Diabetology
Background:
- Islet cell antigen 512 (ICA512) is a neuroendocrine islet autoantigen.
- Autoantibodies to ICA512 (ICA512AA) are implicated in diabetes pathogenesis.
- Existing assays for ICA512AA may lack optimal sensitivity.
Purpose of the Study:
- To develop and validate a novel radioassay for detecting autoantibodies to ICA512 (ICA512AA).
- To compare the sensitivity and specificity of the new radioassay against existing methods.
Main Methods:
- Development of a radioassay using in vitro transcribed and translated ICA512 protein.
- Utilized a 96-well format with membrane separation for antibody-bound antigen.
- Evaluated assay performance in new-onset diabetic patients, at-risk relatives, and control subjects.
Main Results:
- The developed radioassay demonstrated significantly higher sensitivity compared to an ELISA using a COOH-terminal fragment of ICA512.
- 38% of new-onset diabetic patients and 48% of relatives who developed diabetes were positive for ICA512 autoantibodies.
- Only 1.4% of islet cell antibody-negative relatives tested positive, indicating high specificity.
Conclusions:
- The novel ICA512AA radioassay is a sensitive and specific tool for detecting autoantibodies to this important diabetes autoantigen.
- The assay's design facilitates automated, large-scale screening with minimal serum requirement.
- This assay holds promise for improved early detection and risk stratification in diabetes.
